The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries.
Cancer continues to be a major cause of mortality worldwide, necessitating the need for large scale clinical trials. Clinical research in oncology presents a number of challenges. Multiple new agents are being used for multiple new targets and managing this requires precise clinical expertise, in addition to ample facilities and abundant resources. Further dealing with fragile patients who have undergone
previous treatment can be challenging. Patient recruitment is another key strategic consideration, combined with an increase in the number of patients needed to demonstrate that a therapy provides a
significant benefit for patients.